NZ337589A - [1,4]diazepino[6,7,1-hi]indol-4-ones and there use in treating inflammatory diseases - Google Patents

[1,4]diazepino[6,7,1-hi]indol-4-ones and there use in treating inflammatory diseases

Info

Publication number
NZ337589A
NZ337589A NZ337589A NZ33758998A NZ337589A NZ 337589 A NZ337589 A NZ 337589A NZ 337589 A NZ337589 A NZ 337589A NZ 33758998 A NZ33758998 A NZ 33758998A NZ 337589 A NZ337589 A NZ 337589A
Authority
NZ
New Zealand
Prior art keywords
diazepino
indol
ones
inflammatory diseases
treating inflammatory
Prior art date
Application number
NZ337589A
Other languages
English (en)
Inventor
Yves Pascal
Catherine Burnouf
Bernard Gaudilliere
Henry Jacobelli
Alain Calvet
Adrian Payne
Svein Gunwald Dahl
Original Assignee
Parke Davis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis filed Critical Parke Davis
Publication of NZ337589A publication Critical patent/NZ337589A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/06—Peri-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NZ337589A 1997-04-30 1998-04-30 [1,4]diazepino[6,7,1-hi]indol-4-ones and there use in treating inflammatory diseases NZ337589A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9705422A FR2762841B1 (fr) 1997-04-30 1997-04-30 Diazepino-indolones inhibitrices de phosphodiesterases iv
PCT/EP1998/002827 WO1998049169A1 (en) 1997-04-30 1998-04-30 Phosphodiesterase 4-inhibiting diazepinoindolones

Publications (1)

Publication Number Publication Date
NZ337589A true NZ337589A (en) 2000-10-27

Family

ID=9506517

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ337589A NZ337589A (en) 1997-04-30 1998-04-30 [1,4]diazepino[6,7,1-hi]indol-4-ones and there use in treating inflammatory diseases

Country Status (17)

Country Link
US (1) US6239130B1 (OSRAM)
EP (1) EP0980374B1 (OSRAM)
JP (1) JP2001522367A (OSRAM)
KR (1) KR20010020386A (OSRAM)
AT (1) ATE232534T1 (OSRAM)
AU (1) AU729495B2 (OSRAM)
BR (1) BR9809429A (OSRAM)
CA (1) CA2278217A1 (OSRAM)
DE (1) DE69811360T2 (OSRAM)
DK (1) DK0980374T3 (OSRAM)
ES (1) ES2190083T3 (OSRAM)
FR (1) FR2762841B1 (OSRAM)
HR (1) HRP980231B1 (OSRAM)
MX (1) MXPA99006979A (OSRAM)
NZ (1) NZ337589A (OSRAM)
WO (1) WO1998049169A1 (OSRAM)
ZA (1) ZA983704B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2795731B1 (fr) * 1999-07-02 2001-09-07 Warner Lambert Co PROCEDE DE PREPARATION DE [1,4] DIAZEPINO [6,7,1-hi] INDOL-4-ONES SUBSTITUEES
CA2401697A1 (en) * 2000-03-03 2001-09-07 Pfizer Products Inc. Pyrazole ether derivatives as anti-inflammatory/analgesic agents
EP1161949A1 (en) 2000-06-09 2001-12-12 Warner-Lambert Company Use od diazepinoindoles for the treatment of chronic obstructive pulmonary disease
EP1199074A1 (en) * 2000-09-15 2002-04-24 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of il-12 production
EP1188438A1 (en) * 2000-09-15 2002-03-20 Warner-Lambert Company Pharmaceutical composition for preventing or treating a disease associated with an excess of Il-12 production
WO2002094321A1 (en) * 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Compositions for promoting healing of bone fracture
WO2002094320A1 (en) 2001-05-23 2002-11-28 Tanabe Seiyaku Co., Ltd. Therapeutic compositions for repairing chondropathy
AU2002317377A1 (en) * 2001-07-20 2003-03-03 Cancer Research Technology Limited Biphenyl apurinic/apyrimidinic site endonuclease inhibitors to treat cancer
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US20050187278A1 (en) * 2003-08-28 2005-08-25 Pharmacia Corporation Treatment or prevention of vascular disorders with Cox-2 inhibitors in combination with cyclic AMP-specific phosphodiesterase inhibitors
US20090042951A1 (en) * 2004-02-20 2009-02-12 Robert Danziger Blood Pressure Reduction in Salt-Sensitive Hypertension
WO2005102317A1 (en) * 2004-04-23 2005-11-03 Celgene Corporation Methods of using and compositions comprising pde4 modulators for the treatment and management of pulmonary hypertension
BRPI0610498A2 (pt) * 2005-04-19 2010-06-22 Nycomed Gmbh uso de roflumilast,composição farmacêutica, produto de combinação e kit para o tratamento de hipertensão pulmonar
CA2663436A1 (en) * 2006-10-04 2008-04-10 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-one derivatives as calcium receptor antagonists
RU2009141592A (ru) * 2007-04-11 2011-05-20 Алькон Рисерч, Лтд. (Us) ПРИМЕНЕНИЕ ИНГИБИТОРА TNFα В СОЧЕТАНИИ С АНТИГИСТАМИННЫМ СРЕДСТВОМ ДЛЯ ЛЕЧЕНИЯ АЛЛЕРГИЧЕСКОГО РИНИТА И АЛЛЕРГИЧЕСКОГО КОНЪЮНКТИВИТА
US20090182035A1 (en) * 2007-04-11 2009-07-16 Alcon Research, Ltd. Use of a combination of olopatadine and cilomilast to treat non-infectious rhinitis and allergic conjunctivitis
US20090005381A1 (en) * 2007-06-26 2009-01-01 Philip Manton Brown Methods of treating serotonin-mediated diseases and disorders
RU2012117141A (ru) * 2009-10-01 2013-11-10 Алькон Рисерч, Лтд. Композиции олопатадина и способы их применения
US12472241B2 (en) 2018-12-28 2025-11-18 Regeneron Pharmaceuticals, Inc. Treatment of respiratory disorders with arachidonate 15-lipoxygenase (ALOX15) inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2725719B1 (fr) * 1994-10-14 1996-12-06 Jouveinal Inst Rech Diazepino-indoles inhibiteurs de phosphodiesterases iv

Also Published As

Publication number Publication date
EP0980374A1 (en) 2000-02-23
FR2762841B1 (fr) 1999-07-02
ATE232534T1 (de) 2003-02-15
HRP980231B1 (en) 2002-06-30
AU7765298A (en) 1998-11-24
JP2001522367A (ja) 2001-11-13
FR2762841A1 (fr) 1998-11-06
AU729495B2 (en) 2001-02-01
DK0980374T3 (da) 2003-05-05
US6239130B1 (en) 2001-05-29
MXPA99006979A (es) 2005-04-19
CA2278217A1 (en) 1998-11-05
BR9809429A (pt) 2000-06-13
HRP980231A2 (en) 2000-04-30
ES2190083T3 (es) 2003-07-16
DE69811360D1 (de) 2003-03-20
DE69811360T2 (de) 2003-10-09
WO1998049169A1 (en) 1998-11-05
ZA983704B (en) 1999-10-25
KR20010020386A (ko) 2001-03-15
EP0980374B1 (en) 2003-02-12

Similar Documents

Publication Publication Date Title
HRP980231B1 (en) Phosphodiesterase 4 - inhibiting diazepinoindolones
CA2289851A1 (en) Compounds and methods for the inhibition of the expression of vcam-1
IL112118A0 (en) Diazabicyclic neurokinin antagonists
CA2263417A1 (en) Arylalkanoylpyridazines
IL119461A (en) 4,7-disubstituted -7H-pyrrolo ¬2, 3-d¾pyrimidines
WO1998016523A3 (en) Selective factor xa inhibitors
PL330496A1 (en) Methods of and compositions for treating and preventing tumours, disorders associated with tumours as well as cachexy
ZA99533B (en) Glucocortiocoid-selective antiinflammatory agents.
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
IL137508A0 (en) Glucocorticoid-selective anti-inflammatory agents
WO2001035950A3 (en) Benzamide therapeutics and methods for treating inflammatory bowel disease
WO2000074662A3 (en) Arthritis treatment
IE873339L (en) 6-Benzoxazinyl- and¹6-benzothiazinyl-2,3,4,5-tetrahydropyridazin -3-ones.
NZ332834A (en) Glycosaminoglycan-related carbohydrate derivatives ( 5 saccharide groups ) having 4 to 6 sulphate groups
WO1999012933A3 (en) Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
MXPA02012263A (es) 5-aminoalquil-pirazol[4,3-d]pirimidinas.
WO2002051848A3 (de) Sulfamidothienopyrimidine zur verwendung als phosphodiesterase v-hemmer
WO2002056832A3 (en) Methods to treat autoimmune and inflammatory conditions
CA2206995A1 (en) Use of alkanoyl l-carnitines for the therapeutical treatment of chronic inflammatory bowel diseases
AU3539795A (en) Methods of treating cold symptoms using pentoxifylline
MXPA02012260A (es) 2-aminoalquil-tieno[2,3-d]pirimidinas.
IL143304A0 (en) The use of aryl-substituted cyclobutylalkylamines for treating urinary incontinence
DE69717277D1 (en) Imidazopyridine
IL141164A0 (en) 1,2 tricyclic tetrahydroisoquinoline compounds indicated to be useful in the treatment and prophylaxis of epilepsy, migraine and other disorders
AU6107999A (en) 1,3-benzodiazepines with integrin inhibitory activity for use in the treatment of inflammatory disorders

Legal Events

Date Code Title Description
RENW Renewal (renewal fees accepted)